Medicamen Organics Limited (NSE:MEDIORG)

Medicamen Organics Statistics

Total Valuation

NSE:MEDIORG has a market cap or net worth of INR 386.10 million. The enterprise value is 471.84 million.

Market Cap	386.10M
Enterprise Value	471.84M

Important Dates

The last earnings date was Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

NSE:MEDIORG has 11.70 million shares outstanding. The number of shares has increased by 46.18% in one year.

Current Share Class	11.70M
Shares Outstanding	11.70M
Shares Change (YoY)	+46.18%
Shares Change (QoQ)	+16.63%
Owned by Insiders (%)	72.74%
Owned by Institutions (%)	n/a
Float	3.09M

Valuation Ratios

The trailing PE ratio is 9.02.

PE Ratio	9.02
Forward PE	n/a
PS Ratio	1.01
PB Ratio	1.27
P/TBV Ratio	1.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.34, with an EV/FCF ratio of -6.75.

EV / Earnings	11.66
EV / Sales	1.24
EV / EBITDA	7.34
EV / EBIT	8.09
EV / FCF	-6.75

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.41.

Current Ratio	1.67
Quick Ratio	1.10
Debt / Equity	0.41
Debt / EBITDA	1.92
Debt / FCF	-1.77
Interest Coverage	12.16

Financial Efficiency

Return on equity (ROE) is 17.70% and return on invested capital (ROIC) is 10.31%.

Return on Equity (ROE)	17.70%
Return on Assets (ROA)	7.47%
Return on Invested Capital (ROIC)	10.31%
Return on Capital Employed (ROCE)	18.20%
Revenue Per Employee	3.35M
Profits Per Employee	355,009
Employee Count	62
Asset Turnover	0.78
Inventory Turnover	3.64

Taxes

In the past 12 months, NSE:MEDIORG has paid 13.83 million in taxes.

Income Tax	13.83M
Effective Tax Rate	25.47%

Stock Price Statistics

The stock price has decreased by -46.56% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-46.56%
50-Day Moving Average	40.44
200-Day Moving Average	40.05
Relative Strength Index (RSI)	33.73
Average Volume (20 Days)	8,900

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:MEDIORG had revenue of INR 381.88 million and earned 40.47 million in profits. Earnings per share was 3.66.

Revenue	381.88M
Gross Profit	134.03M
Operating Income	58.33M
Pretax Income	54.30M
Net Income	40.47M
EBITDA	64.31M
EBIT	58.33M
Earnings Per Share (EPS)	3.66

Balance Sheet

The company has 41.30 million in cash and 123.53 million in debt, giving a net cash position of -82.23 million or -7.03 per share.

Cash & Cash Equivalents	41.30M
Total Debt	123.53M
Net Cash	-82.23M
Net Cash Per Share	-7.03
Equity (Book Value)	304.81M
Book Value Per Share	25.75
Working Capital	182.76M

Cash Flow

In the last 12 months, operating cash flow was -45.43 million and capital expenditures -24.47 million, giving a free cash flow of -69.90 million.

Operating Cash Flow	-45.43M
Capital Expenditures	-24.47M
Free Cash Flow	-69.90M
FCF Per Share	-5.97

Margins

Gross margin is 35.10%, with operating and profit margins of 15.28% and 10.60%.

Gross Margin	35.10%
Operating Margin	15.28%
Pretax Margin	14.22%
Profit Margin	10.60%
EBITDA Margin	16.84%
EBIT Margin	15.28%
FCF Margin	n/a

Dividends & Yields

NSE:MEDIORG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-46.18%
Shareholder Yield	n/a
Earnings Yield	10.48%
FCF Yield	-18.11%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NSE:MEDIORG has an Altman Z-Score of 2.99 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.99
Piotroski F-Score	5